EUCAST 关于曲霉属伏立康唑折点、念珠菌属伊曲康唑折点的技术说明，以及抗真菌药物敏感性检测方法文件的更新。
EUCAST technical note on isavuconazole breakpoints for Aspergillus, itraconazole breakpoints for Candida and updates for the antifungal susceptibility testing method documents.
机构信息
Unit of Mycology, Department of Microbiological Surveillance and Research, Statens Serum Institut, Copenhagen, Denmark.
Clinical Microbiology Laboratory, Attikon University Hospital, University of Athens, Athens, Greece; Department of Medical Microbiology and Infectious Diseases, Erasmus MC, Rotterdam, The Netherlands.
出版信息
Clin Microbiol Infect. 2016 Jun;22(6):571.e1-4. doi: 10.1016/j.cmi.2016.01.017. Epub 2016 Feb 3.
The Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST) has determined breakpoints for isavuconazole and Aspergillus and for itraconazole and Candida spp., released a new document summarizing existing and new minimum inhibitory concentration ranges for quality control strains and revised the method documents for yeast and mould susceptibility testing. This technical note is based on the EUCAST isavuconazole and itraconazole rationale documents, version 1.0 of the routine and extended internal quality control for antifungal susceptibility testing as recommended by EUCAST, and the E.Def 7.3, E.Def 9.2 and E.Def 9.3 method documents (http://www.eucast.org).
抗真菌药敏试验（AFST）小组委员会的欧洲抗微生物药物敏感性试验委员会（EUCAST）已经确定了伊曲康唑和曲霉以及伏立康唑和念珠菌属的折点，发布了一份新文件，总结了现有和新的质量控制菌株的最低抑菌浓度范围，并修订了酵母和霉菌药敏试验的方法文件。本技术说明基于 EUCAST 伊曲康唑和伏立康唑原理文件、EUCAST 推荐的常规和扩展抗真菌药敏试验内部质量控制的 1.0 版，以及 E.Def 7.3、E.Def 9.2 和 E.Def 9.3 方法文件（http://www.eucast.org）。
Zotero 插件